dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
Published 5 years ago • 446 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc
-
1:54
dr. wakelee on fda approval of frontline pembrolizumab in nsclc
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:09
dr. farago on opportunities to investigate biomarkers for small cell lung cancer
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
2:04
dr. gandhi on pembrolizumab/chemo findings in nsclc and fda approval
-
1:45
dr. farago on combination of olaparib and temozolomide in small cell lung cancer
-
1:27
fda approval of atezolizumab for nsclc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
1:07
dr. subbiah on the fda approval of pralsetinib in ret nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:03
dr. rizvi discusses pembrolizumab for non-small cell lung cancer
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:56
dr. levy on impact of nivolumab, pembrolizumab approvals in nsclc